title: One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi.
authors.affiliation: Hôpital Saint Vincent de Paul, Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: Gendrel
authors.forename: J L
authors.initials: JL
authors.lastname: Moreno
authors.forename: M
authors.initials: M
authors.lastname: Nduwimana
authors.forename: C
authors.initials: C
authors.lastname: Baribwira
authors.forename: J
authors.initials: J
authors.lastname: Raymond
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002063:Burundi / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D004405:Dysentery, Bacillary / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005243:Feces / Q000382:microbiology; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D015366:Pefloxacin / Q000008:administration & dosage* / Q000627:therapeutic use*; D012762:Shigella dysenteriae
chemical_list: D000890:Anti-Infective Agents; D015366:Pefloxacin